Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.115 USD | +9.31% | +11.39% | -18.48% |
May. 09 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.48% | 197M | |
+4.07% | 111B | |
+11.39% | 105B | |
-13.04% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+2.35% | 13.7B | |
+36.16% | 12.45B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Transcript : Bluebird bio, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 04